In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $488.98 in the prior trading day, Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) closed at $488.37, down -0.12%. In other words, the price has decreased by -$0.12 from its previous closing price. On the day, 1.7 million shares were traded. VRTX stock price reached its highest trading level at $492.8961 during the session, while it also had its lowest trading level at $478.78.
Ratios:
Our goal is to gain a better understanding of VRTX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 33.90. For the most recent quarter (mrq), Quick Ratio is recorded 3.29 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on June 27, 2024, initiated with a Buy rating and assigned the stock a target price of $545.
On April 11, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $438.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $515.Wolfe Research initiated its Outperform rating on February 15, 2024, with a $515 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 10 ’24 when Bozic Carmen sold 2,280 shares for $487.34 per share. The transaction valued at 1,111,135 led to the insider holds 27,819 shares of the business.
Bozic Carmen sold 2,280 shares of VRTX for $1,075,522 on Jun 26 ’24. The EVP and CMO now owns 30,099 shares after completing the transaction at $471.72 per share. On Jun 12 ’24, another insider, Atkinson Edward Morrow III, who serves as the EVP, Chief Technical Ops. Off. of the company, sold 7,288 shares for $478.00 each. As a result, the insider received 3,483,664 and left with 15,972 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRTX now has a Market Capitalization of 126247550976 and an Enterprise Value of 116575535104. As of this moment, Vertex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.68, and their Forward P/E ratio for the next fiscal year is 26.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.39 while its Price-to-Book (P/B) ratio in mrq is 6.80. Its current Enterprise Value per Revenue stands at 11.446 whereas that against EBITDA is 25.433.
Stock Price History:
Over the past 52 weeks, VRTX has reached a high of $496.93, while it has fallen to a 52-week low of $340.20. The 50-Day Moving Average of the stock is 5.99%, while the 200-Day Moving Average is calculated to be 18.51%.
Shares Statistics:
The stock has traded on average 1.16M shares per day over the past 3-months and 884901 shares per day over the last 10 days, according to various share statistics. A total of 257.70M shares are outstanding, with a floating share count of 257.38M. Insiders hold about 0.26% of the company’s shares, while institutions hold 93.07% stake in the company. Shares short for VRTX as of 1719532800 were 4102631 with a Short Ratio of 3.54, compared to 1717113600 on 4348066. Therefore, it implies a Short% of Shares Outstanding of 4102631 and a Short% of Float of 1.59.
